Video
6 Oct 2020
BioVectra's CDMO Capabilities
Content provided by our supplier
BioVectra Inc.

-
CA
-
2015On CPHI since
-
500 - 999Employees
Company types
Other Content from BioVectra Inc. (2)
-
News BioVectra to build Canada's first mRNA vaccine and biomanufacturing facility
The state-of-the-art centre will be built in Prince Edward Island to support domestic biomanufacturing capabilities -
Whitepaper Enabling Commercial Manufacturing for Highly Complex Small Molecule Drugs through Process Engineering and Technological Innovation
This case study presents the successful collaboration between an early-stage company that was struggling with the development of a realistic and economically viable commercial pathway and BioVectra, a CDMO with 50 years of experience.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance